Patients with metastatic solid tumors who used an artificial intelligence-based smartphone app reported significantly reduced pain and had fewer hospital admissions, according to results of a randomized controlled trial presented at Palliative and Supportive Care in Oncology Symposium.

The app, called ePAL, monitored and helped patients address pain related to advanced cancer.